AsymmetRx Medical Overview

  • Founded
  • 2001

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

AsymmetRx Medical General Information


Developer of drug and medical devices. The company has developed p63 gene which is involved in the diagnosis of prostate cancer and many other cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Devices and Supplies
Other Healthcare Services
Primary Office
  • 100 Powder Mill Road
  • Suite 177
  • Acton, MA 01720
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AsymmetRx Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view AsymmetRx Medical’s complete valuation and funding history, request access »

AsymmetRx Medical Executive Team (4)

Name Title Board Seat Contact Info
Peter McKeon Managing Director & Board Member
Frank McKeon Ph.D Executive
Matthew Vincent Ph.D Executive
You’re viewing 3 of 4 executive team members. Get the full list »

AsymmetRx Medical Board Members (1)

Name Representing Role Since
Peter McKeon AsymmetRx Medical Managing Director & Board Member 000 0000
To view AsymmetRx Medical’s complete board members history, request access »

AsymmetRx Medical Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view AsymmetRx Medical’s complete investors history, request access »